© The Financial Times Ltd 2015 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Mar 21, 2015, the consensus forecast amongst 25 polled investment analysts covering Procter & Gamble Co advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on May 20, 2009. The previous consensus forecast advised investors to hold their position in Procter & Gamble Co.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 18 analysts offering 12 month price targets for Procter & Gamble Co have a median target of 92.00, with a high estimate of 105.00 and a low estimate of 83.00. The median estimate represents a 11.77% increase from the last price of 82.31. View Full Financials
In 2014, Procter & Gamble Co reported a dividend of 2.45 USD, which represents a 7.02% increase over last year. The 13 analysts covering the company expect dividends of 2.60 USD for the upcoming fiscal year, an increase of 6.08%. View Full Financials
|Div growth (TTM)||+7.02 %|
On Jan 27, 2015, Procter & Gamble Co reported 2nd quarter 2015 earnings of 1.06 per share. This result under-performed the 1.13 consensus expectations of the 22 analysts following the company but under-performed last year's 2nd quarter results by 12.40 %.
The next earnings announcement is expected on Apr 23, 2015. View Full Interim Financials
|Average growth rate||-2.75 %|
Procter & Gamble Co reported annual 2014 earnings of 4.22 per share on Aug 01, 2014. View Full Annual Financials
|Average growth rate||+0.74 %|
The Procter & Gamble Company had 2nd quarter 2015 revenues of 20.16bn. This missed the 20.62bn consensus estimate of the 19 analysts following the company. This was 3.03 % below the prior year's 2nd quarter results. View Full Interim Financials
|Average growth rate||-2.39 %|
The Procter & Gamble Company had revenues for the full year 2014 of 83.06bn. This was 1.31 % below the prior year's results. View Full Annual Financials
|Average growth rate||+1.30 %|